NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Segal JB, Brotman DJ, Emadi A, et al. Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Jun. (Evidence Reports/Technology Assessments, No. 180.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism

Outcomes of Genetic Testing in Adults with a History of Venous Thromboembolism.

Show details

Appendix GEvidence Tables

Evidence Table 1. Quality of studies addressing Analytic Validity of Tests to Identify Factor V Leiden and Prothrombin G20210A Mutations

Evidence Table 2. Results of tests for detection of factor V leiden

Evidence Table 3. Results of tests for detection of prothrombin G20210A

Evidence Table 4. Results of tests for detection of simultaneous mutations

Evidence Table 5. Quality and applicability of studies addressing Factor V Leiden and Recurrent Venous Thrombosis in Probands

Evidence Table 6. Results for Probands Heterozygous for the Factor V Leiden Mutation

Evidence Table 7. Results for probands homozygous for Factor V Leiden mutation

Evidence Table 8. Results for probands with unspecified Factor V Leiden mutations

Evidence Table 9. Results for probands double heterozygous for Factor V Leiden mutation and prothrombin G20210A mutation

Evidence Table 10. Results for probands heterozygous for prothrombin G20210A

Evidence Table 11. TABLE NOT AVAILABLE

Evidence Table 12. Results for probands homozygous for prothrombin G20210A

Evidence Table 13. Quality of studies addressing Factor V Leiden and Prothrombin G20210A predicting events in family members

Evidence Table 14. FVL predicting events in family members, study characteristics

Evidence Table 15. Results of studies of family members with Factor V Leiden

Evidence Table 16. Characteristics of studies of prothrombin G20210A in family members

Evidence Table 17. Results of studies on prothrombin G20210A predicting events in family members

Evidence Table 18. Characteristics of studies of Factor V Leiden and prothrombin G20210A in pregnant family members

Evidence Table 19. Results of studies of Factor V Leiden and prothrombin G20210A in pregnant family members

Evidence Table 20. Quality of studies using survey designs included for effect of testing on clinicians’ management or effect of testing and results on other outcomes

Evidence Table 21. Study characteristics for studies on effect of testing on clinicians’ management and the effect of testing and results on other outcomes

Evidence Table 22. Study characteristics for studies on the effect of testing on management

Evidence Table 23. Population characteristics for studies addressing other effects of testing

Evidence Table 24. Results for articles addressing the effects of testing on VTE outcomes

Evidence Table 25. Description of Studies Evaluating the Cost-Effectiveness of Testing for Factor V Leiden or Prothrombin G20210A Mutation

Evidence Table 26. Quality Assessment of the Studies Evaluating the Cost-Effectiveness of Testing for Factor V Leiden or Prothrombin G20210A Mutation

Evidence Table 27. Applicability of the Studies Evaluating the Cost-Effectiveness of Testing for Factor V Leiden or Prothrombin G20210A Mutation to Research Question

Bookshelf ID: NBK44598

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...